Understanding how certain proteins help cells change their function
Role of nucleosome architecture in cellular reprogramming
This study is looking at how certain proteins help change the way DNA works in our cells, which could help us understand how to reprogram cells and find better treatments for diseases like cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Dakota NIH-funded |
| Lab location | 1 site (Grand Forks, United States) |
| Project ID | NIH-10907409 on NIH RePORTER |
What this research studies
This research investigates how specific proteins, known as pioneer factors, interact with the structure of DNA to enable cells to change their function. By examining how these proteins can modify the physical barriers of DNA, the study aims to uncover the mechanisms that allow for effective gene activation. The research employs advanced techniques, including CRISPR, to manipulate and observe these interactions in a controlled environment. This could provide insights into how cells can be reprogrammed, which is crucial for understanding various diseases, including cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to misregulation of pioneer factors, such as certain types of cancer.
Not a fit: Patients with conditions unrelated to cellular reprogramming or pioneer factor misregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating diseases by improving our ability to reprogram cells.
How similar studies have performed: Other research has shown promise in understanding the role of pioneer factors in cellular reprogramming, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Grand Forks, United States
- University of North Dakota — Grand Forks, United States (Active)
Researchers
- Principal investigator: Takaku, Motoki — University of North Dakota
- Study coordinator: Takaku, Motoki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.